Table 2.
Results of molecular docking between the bioactive components and the core predicted targets.
Ligand | Proteins | Residues | Hydrogen bonds |
---|---|---|---|
Ohioensin-A | AR | Leu880, Asn705, Met780, Phe876, Leu704, Thr877, Leu701, Leu873, Val746, Trp741, Phe764, Gly708, Met745, Met749, Gln711, Met787 | Met895 (3.1 Å) |
ESR1 | Arg394, Leu391, Phe404, Leu384, Leu387, Glu353, Leu428, Ile424, Leu346, Ala350, Met421, Met343, Thr347, Leu540, Leu525 | His524 (3.0 Å) | |
MAPK3 | Ser286, Pro285, Lys287, Gly262, Leu284, Asn255, Leu258 | Ser263 (2.7 Å) | |
AKT1 | His194, Glu198, Gly294, Thr195, Lys179, Lys163, Leu181, Gly162, Val164, Gly159 and Phe161 | Thr160 (3.1 Å) | |
GAPDH | Ala183, Arg13, Asn316, Ile14, Cys152, Ala123 | Gly100 (2.9 Å) | |
quercetin | AR | Thr877, Met780, Phe876, Leu701, Leu880, Asn705, Phe764, Leu704, Met 749, Met787, Gly708, Val746, Gln711, Leu707 | Leu873 (2.7 Å), Met745 (3.1 Å) |
ESR1 | Leu391, Phe404, Ala350, Ile424, Met421, His524, Leu525, Leu384, Leu349, Leu346 and Glu353 | Leu387 (2.8 Å), Arg394 (3.3 Å), Arg394 (2.7 Å), Gly521 (2.5 Å) | |
MAPK3 | Lys287, Leu258, Leu284, Asn255, Gly259, Gly262 | Pro285 (3.0 Å), Ser263 (2.8 Å) | |
AKT1 | Glu278, Lys276, Phe161, Glu191, His194, Gly294, Leu295, Asp292 | Asp274 (2.9 Å), Ser7 (2.9 Å), Thr5 (3.0 Å) | |
GAPDH | Pro36, Phe37, Thr99, Gly12, Ser98, Gly10, Asn9 | Asp35 (2.8 Å), Asn34 (3.0 Å) | |
beta-sitosterol | AR | Phe891, Leu880, Leu701, Met780, Thr877, Trp741, Leu873, Met745, Met742, Met787, Met749, Arg752, Gln711, Val746, Gly708, Leu707, Leu704, Phe764, Met895 | Asn705 (3.0 Å) |
ESR1 | Arg394, Leu387, Leu391, Leu349, Leu428, Ile424, Met388, Met421, His524, Gly521, Leu384, Leu346, Leu525, Thr347, Met343, Ala350 | Phe404 (3.1 Å), Glu353 (2.4 Å) | |
MAPK3 | Ser283, Pro285, Gly259, Leu258, Asn255, Leu284 and Tyr280 | – | |
AKT1 | Asn279, Gly294, Leu295, Glu191, Phe161, His194, Leu181, Glu198, Lys179, Thr195, Asp292, Val164 | Glu234 (3.0 Å) | |
GAPDH | Phe37, Ile38, Ala183, Ile14, Glu317, Asn316, Thr182, Cys152, Tyr320, Arg13, Thr99, Gly12 and Ser98 | Asp35 (3.1 Å) | |
sitosterol | AR | Thr877, Met780, Met895, Phe891, Leu880, Met742, Leu701, Leu873, Trp741, Val746, Met745, Met787, Met749, Leu707, Arg752, Gly708, Gln711, Phe764, Leu704 | Asn705 (2.9 Å) |
ESR1 | Leu387, Leu391, Leu428, Met388, Ile424, His524, Gly521, Leu384, Met421, Leu525, Trp383, Met343, Thr347, Leu346, Glu353, Ala350, Leu349 | Arg394 (2.1 Å), Phe404 (3.1 Å) | |
MAPK3 | Tyr280, Asn255, Lys287, Pro285, Gly259, Leu258, Leu284, Ser283 | – | |
AKT1 | Val164, Asn279, Glu191, Gly294, Leu295, Leu181, Glu198, His194, Phe161, Thr195, Lys179, Asp292 | Glu234 (3.0 Å) | |
GAPDH | Ser122, Ile14, Arg13, Ala183, Gly12, Asp35, Phe37, Ser98, Thr99 | Cys152 (3.2 Å) |